Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
902.24
861.62
747.66
3,360.75
1,865.22
1,125.33
237.45
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
902.24
861.62
747.66
3,360.75
1,865.22
1,125.33
237.45
Raw Material Cost
466.80
398.03
396.07
1,364.83
843.23
203.96
93.41
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
251.53
206.18
185.36
239.71
158.80
83.50
40.70
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
2.10
1.89
2.89
3.70
1.93
0.84
0.60
Selling and Distribution Expenses
144.28
118.09
132.49
197.06
79.45
48.87
32.79
Other Expenses
-14.91
-11.66
-7.10
-3.91
-6.70
-3.05
-0.64
Total Expenditure (Excl Depreciation)
715.65
607.59
645.77
1,766.17
1,016.41
306.72
161.13
Operating Profit (PBDIT) excl Other Income
186.6
254
101.89999999999999
1594.6000000000001
848.8
818.6
76.3
Other Income
39.66
70.99
69.21
118.32
41.21
-10.53
11.03
Operating Profit (PBDIT)
262.25
353.51
217.37
1,539.78
893.85
797.89
93.02
Interest
2.10
1.89
2.89
3.70
1.93
0.84
0.60
Exceptional Items
40.61
38.73
32.39
-89.93
21.33
0.00
-0.14
Gross Profit (PBDT)
435.44
463.59
351.59
1,995.92
1,021.99
921.36
144.04
Depreciation
46.71
42.16
49.44
64.70
17.72
5.37
4.32
Profit Before Tax
254.05
348.19
197.44
1,381.45
895.53
791.67
87.95
Tax
31.10
44.80
17.16
195.99
129.84
112.44
9.53
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
220.19
302.47
180.58
1,184.92
765.69
679.23
78.42
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
220.19
302.47
180.58
1,184.92
765.69
679.23
78.42
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-0.12
0.44
-0.30
0.54
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
220.07
302.91
180.28
1,185.46
765.69
679.23
78.42
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
3,946.69
3,883.64
3,827.25
4,166.23
3,273.64
972.36
293.20
Earnings per share (EPS)
2.8
3.88
2.29
15.14
9.6
8.51
0.98
Diluted Earnings per share
2.8
3.88
2.29
15.14
9.6
8.51
0.98
Operating Profit Margin (Excl OI)
19.49%
27.9%
13.21%
40.37%
44.76%
71.36%
32.71%
Gross Profit Margin
33.33%
45.3%
33.02%
43.03%
48.96%
70.83%
38.86%
PAT Margin
24.4%
35.11%
24.15%
35.26%
41.05%
60.36%
33.03%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2025 is 4.71% vs 15.23% in Dec 2024
Consolidate Net Profit
YoY Growth in year ended Dec 2025 is -27.34% vs 68.00% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2025 is -21.20% vs 90.62% in Dec 2024
Interest
YoY Growth in year ended Dec 2025 is 10.53% vs -34.48% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2025 has fallen from Dec 2024
Compare Annual Results Of Hangzhou Alltest Biotech Co., Ltd. With
Figures in Million
Consolidate Annual Results
Change(CNY)
Change(%)
Net Sales
902.24
0
902.24
Other Operating Income
0.00
0.00
0.00
Total Operating income
902.24
0
902.24
Raw Material Cost
466.80
0
466.80
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
251.53
0
251.53
Power Cost
0
0
0.00
Manufacturing Expenses
2.10
0
2.10
Selling and Distribution Expenses
144.28
0
144.28
Other Expenses
-14.91
0.00
-14.91
Total Expenditure (Excl Depreciation)
715.65
0
715.65
Operating Profit (PBDIT) excl Other Income
186.59
0.00
186.59
Other Income
39.66
0
39.66
Operating Profit (PBDIT)
262.25
0
262.25
Interest
2.10
0
2.10
Exceptional Items
40.61
0
40.61
Gross Profit (PBDT)
435.44
0
435.44
Depreciation
46.71
0
46.71
Profit Before Tax
254.05
0
254.05
Tax
31.10
0
31.10
Provisions and contingencies
0
0
0.00
Profit After Tax
220.19
0
220.19
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
220.19
0
220.19
Share in Profit of Associates
0
0
0.00
Minority Interest
-0.12
0
-0.12
Other related items
0.00
0.00
0.00
Consolidated Net Profit
220.07
0
220.07
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
3,946.69
0
3,946.69
Earnings per share (EPS)
2.80
0
2.80
Diluted Earnings per share
2.80
0
2.80
Operating Profit Margin (Excl OI)
19.49%
0%
0.00
19.49%
Gross Profit Margin
33.33%
0%
0.00
33.33%
PAT Margin
24.40%
0%
0.00
24.40%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 90.22 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 4.71% vs 15.23% in Dec 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 22.01 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -27.34% vs 68.00% in Dec 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 22.26 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -21.20% vs 90.62% in Dec 2024
Annual - Interest
Interest 0.21 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 10.53% vs -34.48% in Dec 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 19.49%
in Dec 2025Figures in %
YoY Growth in year ended Dec 2025 has fallen from Dec 2024






